Dayimu, Alimu http://orcid.org/0000-0001-9998-7463
Di Lisio, Lorena
Anand, Shubha
Roca-Carreras, Isart
Qian, Wendi
Al-Mohammad, Abdulrahman
Basu, Bristi
Valle, Juan W. http://orcid.org/0000-0002-1999-0863
Jodrell, Duncan http://orcid.org/0000-0001-9360-1670
Demiris, Nikos
Corrie, Pippa http://orcid.org/0000-0003-4875-7021
Funding for this research was provided by:
Celgene (AX-PANC-PI-0101)
Article History
Received: 14 August 2022
Revised: 5 January 2023
Accepted: 17 January 2023
First Online: 22 February 2023
Competing interests
: PC received research funding from Celgene to conduct the SIEGE trial. The remaining authors declare no competing interests.
: The SIEGE trial protocol (ISRCTN71070888) was approved by the Northern Ireland Research Ethics Committee 3 and was performed in accordance with the Declaration of Helsinki and the EU Clinical Trials Directive 2001/20/EC. All patients provided written informed consent.
: Not applicable.